drugset / Trial / NCT04094675

Sirolimus for Cowden Syndrome With Colon Polyposis

NCT04094675 ↗

NaSingle-groupOpen-labelTreatment

Summary

Colon polyposis (the presence of multiple colon polyps) is very common with Cowden syndrome, as over 60% of patients have 50 or more polyps. In a previous clinical trial, some participants had reduction in the number of colon polyps with the use of the medication sirolimus for a very short time period. This study is investigating sirolimus and its effect on the number of colon polyps in patients with Cowden syndrome and polyposis over a 1 year period.

Timeline

Start
2019-09-16
Primary completion
2025-02-01
Completion
2025-06-05

Publications

Drugs

EvaluationDrugModalityDoseRoute
Subject Sirolimus Small molecule 2 mg Oral